Page last updated: 2024-09-05

anidulafungin and l 743,872

anidulafungin has been researched along with l 743,872 in 172 studies

Compound Research Comparison

Studies (anidulafungin)	Trials (anidulafungin)	Recent Studies (post-2010) (anidulafungin)	Studies (l 743,872)	Trials (l 743,872)	Recent Studies (post-2010) (l 743,872)
568	33	331	1,724	75	849

Research

Studies (172)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (2.91)	18.2507
2000's	42 (24.42)	29.6817
2010's	114 (66.28)	24.3611
2020's	11 (6.40)	2.80

Authors

Authors	Studies
Galgiani, JN; Krishnarao, TV	1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA	2
Espinel-Ingroff, A	1
Baquero, F	1
Ernst, EJ; Klepser, ME; Pfaller, MA	1
Graybill, JR	2
Arathoon, EG	1
Ernst, EJ; Klepser, ME; Lewis, RE; Pfaller, MA; Roling, EE; Wasson, A	1
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A	1
Gupta, AK; Tomas, E	1
Daschner, FD; Engels, I; Frank, U; Greiner, M	1
Darouiche, RO	1
Theuretzbacher, U	1
Steinbach, WJ	1
Alexander, BD; Zaas, AK	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Morrison, VA	1
Burgess, DS; Carden, M; Cota, J; Graybill, JR; Najvar, LK; Wiederhold, NP	1
Bennett, JE	1
Morris, MI; Villmann, M	1
Graninger, W; Joukhadar, C; Presterl, E; Wagner, C	1
Jacobsen, MD; Odds, FC; Whyte, JA	1
Bocanegra, R; Graybill, JR; Molina, D; Najvar, LK; Olivo, M; Wiederhold, NP	1
Cappelletty, D; Eiselstein-McKitrick, K	1
Garcia-Effron, G; Hsu, MJ; Kahn, JN; Marr, KA; Park, S; Perlin, DS	1
Balashov, S; Delmas, G; Garcia-Effron, G; Paderu, P; Park, S; Perlin, DS	1
Khachikian, D; Kim, R; Reboli, AC	1
Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, V; Rex, JH	1
Antachopoulos, C; Meletiadis, J; Roilides, E; Sein, T; Walsh, TJ	1
Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	2
Fleischhacker, M; Radecke, C; Ruhnke, M; Schulz, B	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Holliday, NM; Killian, SB; Knapp, CC; Messer, SA; Miskov, A; Pfaller, MA; Ramani, R	1
Clemons, KV; Martinez, M; Stevens, DA; Tong, AJ; van Asbeck, E	1
Alexander, BD; Andes, D; Brown, SD; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Knapp, CC; Ostrosky-Zeichner, L; Pfaller, MA; Rex, JH; Sheehan, DJ; Walsh, TJ	1
Garcia-Effron, G; Grabinski, JL; Lee, SA; Perlin, DS; Wiederhold, NP	1
Garcia-Effron, G; Park, S; Perlin, DS	1
Baxa, D; Buhari, M; Chandra, J; Chen, A; Ghannoum, MA; Golembieski, A; Mukherjee, PK; Vazquez, JA	1
Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A	1
Martín Mazuelos, E; Rodríguez-Tudela, JL	1
Azanza, JR; Montejo, M	1
Balcer, HE; Chahine, EB; Sucher, AJ	1
Guarro, J; Mariné, M; Pastor, FJ; Pontón, J; Quindós, G; Sahand, IH	1
Dirks, D; Hazen, KC; Masuoka, J	1
Arendrup, MC; Cuenca-Estrella, M; Garcia-Effron, G; Lass-Flörl, C; Lopez, AG; Perlin, DS; Rodriguez-Tudela, JL	1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S; Turnidge, J	1
Bal, AM	1
Canton, E; Espinel-Ingroff, A; Martín-Mazuelo, E; Peman, J	1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ	1
Coote, PJ; Harris, MR	1
Cantón, E; Castro, C; González, A; González, MT; Martín-Mazuelos, E; Martos, AI; Pemán, J; Romero, A; Serrano, C	1
Cantón, E; del Castillo, L; Espinel-Ingroff, A; Pemán, J	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Bakker-Woudenberg, IA; Fahal, AH; van Belkum, A; van de Sande, WW	1
Andes, D; Bohrmuller, J; Diekema, DJ; Lepak, A; Marchillo, K; Pfaller, MA	1
Chandrasekar, PH; Cutright, JL; Krishnan-Natesan, S; Manavathu, EK	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Barre, O; Gay-Andrieu, F; Le Pape, P; Miegeville, M; Morio, F; Thierry, G	1
Ahlquist, AM; Chiller, T; Farley, MM; Harrison, LH; Iqbal, N; Lockhart, SR; Zimbeck, AJ	1
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B	1
Ben-Ami, R; Kontoyiannis, DP; Lewis, RE	1
Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S	1
Arendrup, MC; Cuenca-Estrella, M; Delmas, G; Garcia-Effron, G; Gomez-Lopez, A; Park, S; Perlin, DS; Rodriguez-Tudela, JL	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ	1
Andes, D; Arendrup, MC; Brown, SD; Diekema, DJ; Lockhart, SR; Motyl, M; Perlin, DS; Pfaller, MA	1
Cantón, E; Espinel-Ingroff, A	1
Fadda, G; Fiori, B; Perlin, DS; Posteraro, B; Sanguinetti, M; Torelli, R; Tumbarello, M	1
Kofla, G; Ruhnke, M	1
Glöckner, A	1
Wilke, M	1
Hou, J; Kontoyiannis, DP; Lewis, RE; Liao, G; Prince, RA	1
Arendrup, MC; Axner-Elings, M; Botero-Kleiven, S; Jensen, RH	1
Bujdáková, H; Kucharíková, S; Lagrou, K; Tournu, H; Van Dijck, P	1
Ahmad, S; Chandy, R; Joseph, L; Khan, Z; Theyyathel, A	1
Edlind, TD; Johnson, ME; Katiyar, SK	1
Le Guyader, N; Leverger, G	1
Andes, DR; Baddley, JW; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lockhart, SR; Marr, KA; Pappas, PG; Walsh, TJ; Zimbeck, AJ	1
Collins, MS; Cushion, MT	1
Alastruey-Izquierdo, A; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Livermore, J; Perlin, DS; Sharp, A; Warn, PA	1
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Baltch, A; Bopp, LH; Michelsen, PP; Ritz, WJ; Smith, RP	1
Lopes, V; Pinto, E; Pinto, P; Ramos, H; Vale-Silva, LA	1
Attri, A; Badali, H; Bayat, M; Chander, J; de Hoog, GS; Handa, U; Meis, JF; Rani, H; Seyedmousavi, S; Sidhu, S	1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA	1
Barchiesi, F; Giannini, D; Manso, E; Orlando, F; Posteraro, B; Sanguinetti, M; Spreghini, E	1
Cortés L, JA; Russi N, JA	1
Arendrup, MC; Goodwin, J; Hope, W; Howard, SJ; Jensen, RH; Perlin, DS	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Ingham, CJ; Schneeberger, PM	1
Andes, D; Castanheira, M; Diekema, D; Lepak, A; Pfaller, M	1
Cantón, E; Espinel-Ingroff, A; Hervás, D; Pemán, J	1
Aznar-Marín, P; García-Agudo, L; García-Martos, P; Marín-Casanova, P; Martos-Cañadas, J; Rodríguez-Iglesias, M	1
Katragkou, A; Kyrpitzi, D; Peshkova, P; Roilides, E; Simitsopoulou, M; Tasina, E; Velegraki, A; Walsh, TJ	1
Burgmann, H; Forstner, C; Poeppl, W; Schranz, H; Tobudic, S; Vychytil, A	1
Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E	1
Arendrup, MC; Bonfietti, LX; Bustamante, B; Canton, E; Chryssanthou, E; Cuenca-Estrella, M; Dannaoui, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gaustad, P; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Meis, JF; Moore, CB; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Pukinskas, SR; St-Germain, G; Szeszs, MW; Turnidge, J	1
Cleary, JD; Farley, JM; Kyle, PB; Stover, KR	1
Clancy, CJ; Nguyen, MH; Press, EG; Shields, RK; Updike, CL	1
Alffenaar, JW; Greijdanus, B; Santoe, RN; Uges, DR; van der Elst, KC; van Hateren, K; van Wanrooy, MJ; Wessels, AM; Wilmer, CM	1
Esposto, MC; Prigitano, A; Tortorano, AM	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA; Woosley, LN	1
Dimopoulou, D; Hamilos, G; Kontoyiannis, DP; Lewis, RE; Samonis, G; Tzardi, M	1
Cleary, JD; King, ST; Stover, KR	1
Carver, PL; Chen, S; Clancy, CJ; Clarke, LG; Eschenauer, GA; Hanson, KE; Klinker, KP; Kubin, CJ; Lam, SW; Morris, AJ; Nguyen, MH; Pasculle, WA; Potoski, BA; Shields, RK; Shoham, S; Vazquez, JA	1
Borens, O; Furustrand Tafin, U; Maiolo, EM; Trampuz, A	1
Bernardo, SM; Lee, SA; Walraven, CJ; Wiederhold, NP	1
Kyrpitzi, D; Roilides, E; Simitsopoulou, M; Velegraki, A; Walsh, TJ	1
Beldavs, ZG; Bolden, CB; Chiller, TM; Cleveland, AA; Farley, MM; Harrison, LH; Iqbal, N; Kuykendall, RJ; Lockhart, SR; Park, BJ; Pham, CD; Schaffner, W	1
Castanheira, M; Diekema, DJ; Jones, RN; Pfaller, MA	1
Chua, NG; Kwa, AL; Lee, W; Lingegowda, PB; Zhou, YP	1
Cornely, OA; Franke, B; Glossmann, J; Heimann, SM; Kochanek, M; Langebartels, G; Padosch, SA; Reiner, M; Reuter, H; Seifert, H; Stippel, D; Vehreschild, JJ; Vehreschild, MJ; Vierzig, A; Wisplinghoff, H	1
Arens, C; Henrich, M; Koch, C; Li, L; Lichtenstern, C; Niemann, B; Rohrbach, S; Schulte, A; Uhle, F; Weigand, MA; Wolff, M	1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R	1
Cantón, E; Eraso, E; Gil-Alonso, S; Jauregizar, N; Quindós, G	1
Akova, M; Bassetti, M; De Waele, JJ; Dimopoulos, G; Kaukonen, KM; Koulenti, D; Lipman, J; Martin, C; Montravers, P; Rello, J; Rhodes, A; Roberts, JA; Sinnollareddy, MG; Starr, T; Wallis, SC	1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Lempers, VJ; Muilwijk, EW; Pickkers, P; Warris, A	1
Balbino, S; Caggiano, G; Coretti, C; De Giglio, O; Iatta, R; Lovero, G; Martinelli, D; Montagna, MT; Rosato, A	1
Juvvadi, PR; Lamoth, F; Moseley, MA; Muñoz, A; Read, ND; Soderblom, EJ; Steinbach, WJ	1
Cleary, JD; Stover, KR	2
Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA	1
Alvarez-Fernandez, M; Borrell Solé, N; Cantón, E; Carver, PL; Chen, SC; Echeverria, J; Eschenauer, G; Esperalba, J; Espinel-Ingroff, A; García García, I; Garcia-Effron, G; Getsinger, DL; Gómez-G de la Pedrosa, E; Gonzalez, GM; Govender, NP; Grancini, A; Guinea, J; Hanson, KE; Kidd, SE; Klinker, K; Kubin, CJ; Kus, JV; Linares, MJ; Lockhart, SR; Marco, F; Meletiadis, J; Merino, P; Morris, AJ; Pelaez, T; Pemán, J; Pérez Del Molino, L; Perlin, DS; Quindós, G; Rodriguez-Iglesias, M; Roselló Mayans, E; Rubio Calvo, C; Ruiz Pérez de Pipaon, M; Sánchez-Reus, F; Sanguinetti, M; Shields, R; Shoham, S; Turnidge, J; Wengenack, NL; Yagüe, G	1
Jiang, Y; Jung, DS; Kontoyiannis, DP; Tverdek, FP	1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF	1
Auzinger, G; Charbonneau, C; Graham, CN; Kantecki, M; Knox, HN; Playford, EG; Schlamm, H; Weinstein, D	1
Henrich, M; Koch, C; Lichtenstern, C; Uhle, F; Weigand, MA; Wolff, M	1
Bouza, E; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Perlin, DS	1
Ghannoum, M; Katragkou, A; Petraitis, V; Roilides, E; Walsh, TJ	1
Ge, T; Liao, S; Xu, G; Yang, J; Zhu, L	1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S	1
Akoumianaki, T; Albert, N; Andrianaki, A; Chamilos, G; Ioannou, P; Kontoyiannis, DP; Kyrmizi, I; Perlin, D; Samonis, G	1
Groeneveld, AB; Rijnders, BJ; van der Geest, PJ; Vonk, AG	1
Bouza, E; Escribano, P; Gómez-Perosanz, M; Guinea, J; Marcos-Zambrano, LJ; Zaragoza, O	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR	1
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E	1
Capilla, J; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, NP	1
Ahmad, N; Ginsapu, SJ; Gowbei, A; Hashim, R; Ho Betty, LS; Ramli, NY; Razak, MF; Sabaratnam, P; Sipiczki, M; Suppiah, J; Tap, RM	1
Almaguer, AL; Bartizal, K; Locke, JB; Zuill, DE	1
Rustchenko, E; Suwunnakorn, S; Wakabayashi, H	1
Bouza, E; Escribano, P; Guinea, J; Marcos-Zambrano, LJ; Sánchez-Carrillo, C	1
Barber, KE; Cretella, D; King, ST; Stover, KR	1
Chang, CC; Chen, SC; Slavin, MA	1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K	1
Aigner, M; Erbeznik, T; Gschwentner, M; Lass-Flörl, C	1
Charbonneau, C; Chen, YC; Lee, TY; Ou, HT	1
Majumdar, S; Patil, A	1
Arango, K; Berrio, I; Cano, LE; De Bedout, C; Gómez, BL; Jiménez-Ortigosa, C; Maldonado, N; Perlin, DS; Robledo, C; Robledo, J; Valencia, Y	1
Clancy, CJ; Healey, KR; Kline, EG; Kordalewska, M; Nguyen, MH; Perlin, DS; Shields, RK	1
Bai, X; Feng, S; Gao, W; Li, J; Li, X; Quan, C; Xue, Y; Zhao, P; Zhao, Z; Zu, X	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R	1
Berrio, I; Dudiuk, C; Gamarra, S; Garcia-Effron, G; Leonardelli, F; Macedo, D; Marin, A; Morales-Lopez, S; Salcedo, S; Theill, L; Yesid-Rodriguez, J	1
Arastehfar, A; Berman, J; Boekhout, T; Kostrzewa, M; Lass-Flörl, C; Sparbier, K; Vatanshenassan, M	1
Brillowska-Dabrowska, A; Mroczyńska, M	1
Li, Y; Liu, D; Liu, X; Pan, Y	1
Alvarez, ME; Cuenca-Estrella, M; Fortun, J; Gioia, F; Gomez-García de la Pedrosa, E; Gomez-Lopez, A; Martín-Davila, P; Moreno, S	1
Chen, J; Chu, Y; Han, X; Shang, H; Tian, S; Wang, Q; Zhou, B	1
Droll, MC; Henrich, M; Koch, C; Müller, S; Sander, M; Weigand, MA; Weiterer, S	1
Farooqi, J; Jabeen, K; Memon, S; Naqvi, SF; Zafar, A; Zafar, U	1
Fridman, M; Jaber, QZ; Logviniuk, D; Yona, A	1
Bretagne, S; Desnos-Ollivier, M; Dromer, F; Lortholary, O	1
Farooqi, J; Ghanchi, NK; Jabeen, K; Memon, S; Zafar, U; Zaka, S	1
Balázs, B; Balogh, B; Bozó, A; Forgács, L; Kelentey, B; Kovács, R; Majoros, L; Tóth, Z	1
He, C; Kang, W; Li, J; Wang, T; Xu, Y; Yu, J; Zhang, G; Zhang, J; Zhao, Y	1
Abdorahimi, M; Ahmadikia, K; Badali, H; Gharehbolagh, SA; Khodavaisy, S; Mahmoudi, S; Meis, JF; Rezaie, S	1

Reviews

33 review(s) available for anidulafungin and l 743,872

Article	Year
Hitting a new target with echinocandins. Why chase something else? Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:4 Topics: Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Peptides; Peptides, Cyclic	2001
Clinical efficacy of echinocandin antifungals. Current opinion in infectious diseases, 2001, Volume: 14, Issue:6 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Mycoses; Peptides; Peptides, Cyclic	2001
New antifungal agents. Dermatologic clinics, 2003, Volume: 21, Issue:3 Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2003
Pharmacokinetics/pharmacodynamics of echinocandins. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Protein Binding; Tissue Distribution	2004
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Echinocandins: role in antifungal therapy, 2005. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Mycoses; Peptides, Cyclic	2005
Echinocandin antifungals: review and update. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Caspofungin; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic	2006
Echinocandins for candidemia in adults without neutropenia. The New England journal of medicine, 2006, Sep-14, Volume: 355, Issue:11 Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic	2006
Echinocandins in the management of invasive fungal infections, Part 2. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Oct-01, Volume: 63, Issue:19 Topics: Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Catheterization; Critical Care; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Transplants	2006
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology, 2006, Volume: 78, Issue:4 Topics: Actins; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liver; Liver Failure; Micafungin; Models, Chemical; Peptides, Cyclic; Rats	2006
The echinocandins. Pharmacotherapy, 2007, Volume: 27, Issue:3 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Candida albicans; Caspofungin; Cryptococcus; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic	2007
A comparative evaluation of properties and clinical efficacy of the echinocandins. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Enzyme Inhibitors; Glucosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Treatment Outcome	2007
[In vitro activity of anidulafungin. Comparison with the activity of other echinocandins]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Anidulafungin; Antifungal Agents; Aspergillus; beta-Glucans; Candida; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Glucosyltransferases; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity	2008
[Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Monitoring; Echinocandins; Gastrointestinal Diseases; Half-Life; Humans; Immunosuppressive Agents; Lipopeptides; Liver; Liver Failure; Mycoses; Obesity; Renal Insufficiency; Tissue Distribution	2008
Echinocandins: the newest class of antifungals. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses	2009
The echinocandins: three useful choices or three too many? International journal of antimicrobial agents, 2010, Volume: 35, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Clinical Trials as Topic; Echinocandins; Humans; Lipopeptides; Micafungin	2010
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2011, Volume: 14, Issue:3 Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Proteoglycans; Randomized Controlled Trials as Topic; Species Specificity; Treatment Outcome	2011
In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same? Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Anidulafungin; Candida; Candidiasis; Caspofungin; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Humans; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity; Therapeutic Equivalency	2011
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candidiasis, Invasive; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Molecular Structure	2011
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Guidelines as Topic; Humans; Lipopeptides; Micafungin	2011
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Echinocandins; Humans; Lipopeptides; MEDLINE; Micafungin	2011
[Echinocandins]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2011, Volume: 28, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Candida; Caspofungin; Clinical Trials as Topic; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Cardiac toxicity of the echinocandins: chance or cause and effect association? Journal of clinical pharmacy and therapeutics, 2014, Volume: 39, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Echinocandins; Heart; Humans; Lipopeptides	2014
Impact of special patient populations on the pharmacokinetics of echinocandins. Expert review of anti-infective therapy, 2015, Volume: 13, Issue:6 Topics: Adolescent; Adult; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Child; Critical Illness; Drug Interactions; Echinocandins; Hematologic Diseases; Humans; Infant, Newborn; Kidney; Lipopeptides; Liver; Micafungin; Microbial Sensitivity Tests; Obesity	2015
Antifungal-Associated Drug-Induced Cardiac Disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Cardiac Output; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiotoxicity; Caspofungin; Echinocandins; Echocardiography; Humans; Lipopeptides; Mitochondria, Heart	2015
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:9 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence	2016
New developments and directions in the clinical application of the echinocandins. Archives of toxicology, 2017, Volume: 91, Issue:4 Topics: Administration, Intravenous; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candidiasis; Caspofungin; Drug Administration Schedule; Drug Interactions; Echinocandins; Humans; Lipopeptides; Micafungin	2017
Echinocandins in antifungal pharmacotherapy. The Journal of pharmacy and pharmacology, 2017, Volume: 69, Issue:12 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses	2017
Fungi-derived lipopeptide antibiotics developed since 2000. Peptides, 2019, Volume: 113 Topics: Anidulafungin; Anti-Infective Agents; Caspofungin; Depsipeptides; Echinocandins; Fungal Proteins; Fungi; Lipopeptides; Micafungin; Structure-Activity Relationship	2019
Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles	2019
Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6 Topics: Anidulafungin; Antifungal Agents; Area Under Curve; Caspofungin; Critical Illness; Echinocandins; Humans; Invasive Fungal Infections; Micafungin	2020
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC infectious diseases, 2020, Nov-11, Volume: 20, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Micafungin; Prevalence	2020

Other Studies

139 other study(ies) available for anidulafungin and l 743,872

Article	Year
Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Solubility; Solvents	1997
In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagnostic microbiology and infectious disease, 1998, Volume: 30, Issue:4 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Fusarium; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Rhizopus	1998
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. Journal of clinical microbiology, 1998, Volume: 36, Issue:10 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Culture Media; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Structure-Activity Relationship; Triazoles; Yeasts	1998
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp. Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:1 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test	1998
[Antifungal drugs: the new frontier]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole	1998
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Polyenes	2000
The echinocandins, first novel class of antifungals in two decades: will they live up to their promise? International journal of clinical practice, 2001, Volume: 55, Issue:9 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cell Wall; Echinocandins; Fungi; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides; Peptides, Cyclic; Randomized Controlled Trials as Topic	2001
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:1 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candida; Caspofungin; Cell Division; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Lipopeptides; Logistic Models; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Time Factors	2002
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole	2003
Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:9 Topics: Anidulafungin; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Phagocytes; Phagocytosis; Respiratory Burst; Sampling Studies; Sensitivity and Specificity	2004
Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Esophageal Diseases; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic	2004
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Colorimetry; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Tetrazolium Salts	2006
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic	2007
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peptides, Cyclic; Serum	2007
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Amino Acid Sequence; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Protein Subunits	2007
Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides, Cyclic; Serum	2007
Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anidulafungin; Aspergillus; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Protein Binding; Serum	2007
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Spores, Fungal	2008
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. Journal of clinical microbiology, 2008, Volume: 46, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests	2008
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 2008, Volume: 46, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results; Sensitivity and Specificity	2008
Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique	2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. Journal of clinical microbiology, 2008, Volume: 46, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Statistics as Topic; Treatment Outcome	2008
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anidulafungin; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; DNA Mutational Analysis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Point Mutation	2008
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Anidulafungin; Candida albicans; Caspofungin; Echinocandins; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2009
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15, Issue:3 Topics: Anidulafungin; Antifungal Agents; Burn Units; Burns; Candida; Candidiasis; Carrier State; Caspofungin; Echinocandins; Environmental Microbiology; Fungal Proteins; Genotype; Glucosyltransferases; Health Personnel; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Sequence Analysis, DNA	2009
In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2009
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. Journal of clinical microbiology, 2009, Volume: 47, Issue:10 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2009
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Male; Micafungin; Mice	2009
Determination of Echinocandin MICs for Candida species in less than 8 hours: comparison of the rapid susceptibility assay with the Clinical and Laboratory Standards Institute's broth microdilution assay. Journal of clinical microbiology, 2009, Volume: 47, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Culture Media; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity	2009
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Culture Media; Echinocandins; Indicator Dilution Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Reference Standards	2010
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. Journal of clinical microbiology, 2010, Volume: 48, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2010
Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Reference Standards	2010
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro. International journal of antimicrobial agents, 2010, Volume: 35, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Antimicrobial Cationic Peptides; Body Weight; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Humans; Kidney; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability	2010
Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Medical mycology, 2010, Volume: 48, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Fusarium; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycology	2010
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microbiological Techniques; Time Factors	2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Journal of clinical microbiology, 2010, Volume: 48, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2010
Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Madurella; Micafungin; Microbial Sensitivity Tests; Mycetoma	2010
In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Female; Kidney; Lipopeptides; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding; Species Specificity	2010
Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Female; Fluconazole; Humans; Immunocompromised Host; Kidney; Lipopeptides; Mice; Mice, Inbred ICR; Neutropenia; Spleen; Treatment Outcome	2010
[Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®]. Pathologie-biologie, 2011, Volume: 59, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; France; Fungal Proteins; Glycosyltransferases; Hospitals, University; Humans; In Vitro Techniques; Infant; Infant, Newborn; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Ribotyping; Species Specificity; Young Adult	2011
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction	2010
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole	2010
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods. Medical mycology, 2011, Volume: 49, Issue:3 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 2011, Volume: 49, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Caspofungin; Cattle; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Serum Albumin, Bovine	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole	2011
In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Biofilms; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Lipopeptides; Microbial Sensitivity Tests	2011
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Lipopeptides; Mice; Mice, Inbred BALB C; Treatment Outcome	2011
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. Journal of clinical microbiology, 2011, Volume: 49, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation, Missense; Sweden	2011
Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 9 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Caspofungin; Cell Adhesion; Culture Media; Echinocandins; Fungal Proteins; Gene Expression; Humans; Hydrogen-Ion Concentration; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Polystyrenes	2011
Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Retrospective Studies	2011
New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8 Topics: Anidulafungin; Antifungal Agents; Base Sequence; beta-Glucans; Candida glabrata; Caspofungin; Cell Wall; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Lipopeptides; Membrane Proteins; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Proteoglycans; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Scedosporium; Sequence Alignment; Sequence Analysis, DNA	2011
[Echinocandins in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18 Suppl 1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis, Invasive; Caspofungin; Child; Echinocandins; Evidence-Based Medicine; Humans; Injections, Intravenous; Lipopeptides; Micafungin; Mycoses; Treatment Outcome	2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Transplantation	2011
Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Adenosine Triphosphate; Anidulafungin; Animals; Antifungal Agents; Biofilms; Caspofungin; Drug Resistance, Fungal; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pneumocystis carinii; Pneumocystis Infections; Rats	2011
Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia	2011
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11 Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis. Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycology	2012
Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient. Medical mycology, 2012, Volume: 50, Issue:2 Topics: Anidulafungin; Antifungal Agents; Caspofungin; Cysts; DNA, Fungal; DNA, Ribosomal Spacer; Echinocandins; Exophiala; Humans; Immunocompetence; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Phaeohyphomycosis	2012
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2012
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Candida glabrata; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Kidney; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities. PloS one, 2012, Volume: 7, Issue:4 Topics: Aluminum Oxide; Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Culture Media; Culture Techniques; Echinocandins; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Spores, Fungal	2012
Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida glabrata; Candidiasis, Invasive; Caspofungin; Echinocandins; Female; Fungal Proteins; Glucosyltransferases; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation	2012
Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Viability; Time Factors	2013
Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colorimetry; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity; Time Factors	2012
Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidemia; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton; Species Specificity	2013
Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids. Mycoses, 2013, Volume: 56, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida albicans; Caspofungin; Dialysis Solutions; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Peritoneal Dialysis; Time Factors	2013
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients. Annals of hematology, 2014, Volume: 93, Issue:3 Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors	2014
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Europe; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; North America; Observer Variation; South America; Species Specificity	2013
Cardiac toxicity of some echinocandin antifungals. Expert opinion on drug safety, 2014, Volume: 13, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Male; Micafungin; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Contraction; Myofibrils; Rats; Rats, Sprague-Dawley; Toxicity Tests	2014
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2013
Simultaneous quantification of anidulafungin and caspofungin in plasma by an accurate and simple liquid chromatography tandem mass-spectrometric method. Therapeutic drug monitoring, 2013, Volume: 35, Issue:6 Topics: Adult; Anidulafungin; Antifungal Agents; Calibration; Caspofungin; Child; Child, Preschool; Chromatography, Liquid; Drug Monitoring; Drug Stability; Drug Storage; Echinocandins; Humans; Infant; Lipopeptides; Male; Reproducibility of Results; Tandem Mass Spectrometry	2013
Comparison of effects of human serum and horse serum on in vitro susceptibility testing of echinocandins. Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Caspofungin; Echinocandins; Horses; Humans; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Serum	2014
Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2014
Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C	2014
Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2014
Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Biofilms; Calorimetry; Candida; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Plankton	2014
Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Medical mycology, 2014, Volume: 52, Issue:2 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron; Mutant Proteins; Staining and Labeling	2014
Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Catheters; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton	2014
Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; United States	2014
Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria. Journal of clinical microbiology, 2014, Volume: 52, Issue:9 Topics: Anidulafungin; Antifungal Agents; Biomarkers; Candida; Caspofungin; Diagnostic Errors; Echinocandins; Fungal Proteins; Glucosyltransferases; Humans; Lipopeptides; Microbial Sensitivity Tests; Mutant Proteins	2014
Echinocandin-induced eosinophilia: a case report. Scandinavian journal of infectious diseases, 2014, Volume: 46, Issue:11 Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Eosinophilia; Female; Humans; Lipopeptides	2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidemia; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Health Care Costs; Hospitalization; Humans; Infant; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Treatment Outcome; Young Adult	2015
Cardiac effects of echinocandins after central venous administration in adult rats. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; DNA, Mitochondrial; Echinocandins; Heart Failure; Heart Ventricles; Hemodynamics; Lipopeptides; Male; Micafungin; Rats; Rats, Inbred Lew	2015
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses, 2015, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole	2015
In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Critical care (London, England), 2015, Feb-04, Volume: 19 Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Critical Illness; Drug Monitoring; Echinocandins; Europe; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Middle Aged	2015
Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. BMC microbiology, 2015, May-20, Volume: 15 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Hospitals, University; Humans; Italy; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2015
Calcium-Mediated Induction of Paradoxical Growth following Caspofungin Treatment Is Associated with Calcineurin Activation and Phosphorylation in Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcium; Caspofungin; Echinocandins; Egtazic Acid; Fungal Proteins; Lipopeptides; Micafungin; Phosphorylation	2015
Cardiac response to centrally administered echinocandin antifungals. The Journal of pharmacy and pharmacology, 2015, Volume: 67, Issue:9 Topics: Anidulafungin; Animals; Antifungal Agents; Blood Pressure; Cardiac Output; Caspofungin; Echinocandins; Heart; Heart Rate; Lipopeptides; Male; Micafungin; Rats; Rats, Sprague-Dawley	2015
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. BMC infectious diseases, 2015, Jul-03, Volume: 15 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole	2015
Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2015
Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Caspofungin; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Humans; Lipopeptides; Liver Function Tests; Male; Middle Aged; Mycoses; Neoplasms; Retrospective Studies; Young Adult	2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC infectious diseases, 2015, Oct-26, Volume: 15 Topics: Anidulafungin; Antifungal Agents; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Drug Costs; Echinocandins; Fluconazole; Humans; Intensive Care Units; Length of Stay; Lipopeptides; Micafungin; Models, Economic; Treatment Outcome; United Kingdom	2015
Cardiac Effects of Echinocandins in Endotoxemic Rats. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Cardiac Output; Cardiac Volume; Caspofungin; Echinocandins; Endotoxemia; Female; Heart; Hemorheology; Humans; Lipopeptides; Lipopolysaccharides; Male; Micafungin; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Inbred Lew; Shock, Septic	2016
Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production. Medical mycology, 2016, Volume: 54, Issue:2 Topics: Anidulafungin; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candidemia; Caspofungin; Echinocandins; Gentian Violet; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Oxidation-Reduction; Portugal; Staining and Labeling; Tetrazolium Salts	2016
Echinocandin Resistance in Candida. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Antifungal Agents; Azoles; Candida; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Glucosyltransferases; Humans; Intraabdominal Infections; Lipopeptides; Micafungin; Mutation	2015
The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices	2015
Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients. International journal of antimicrobial agents, 2015, Volume: 46, Issue:6 Topics: Adolescent; Adult; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Caspofungin; Child; Child, Preschool; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Monte Carlo Method	2015
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae. Antimicrobial agents and chemotherapy, 2015, Dec-07, Volume: 60, Issue:3 Topics: Albumins; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Culture Media; Echinocandins; Humans; Hyphae; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole	2015
Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections. Mycoses, 2016, Volume: 59, Issue:3 Topics: Administration, Intravenous; Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Critical Illness; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Multivariate Analysis; Retrospective Studies	2016
Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2016
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Candida; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Half-Life; Humans; Lipopeptides; Microbial Sensitivity Tests	2016
Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa. Diagnostic microbiology and infectious disease, 2016, Volume: 86, Issue:1 Topics: Anidulafungin; Animal Structures; Animals; Antifungal Agents; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fungemia; Lipopeptides; Male; Mice; Saccharomycetales; Survival Analysis; Treatment Outcome	2016
First isolation of Candida wangnamkhiaoensis from the blood of immunocompromised paediatric patient. Mycoses, 2016, Volume: 59, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Caspofungin; Child, Preschool; DNA, Ribosomal Spacer; Echinocandins; Fluconazole; Humans; Hyphae; Immunocompromised Host; Lipopeptides; Male; Phylogeny; Polymerase Chain Reaction; Sequence Alignment; Voriconazole	2016
Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Caspofungin; Culture Media; Drug Resistance, Fungal; Echinocandins; Genetic Loci; Lipopeptides; Microbial Sensitivity Tests; Mutation	2016
Chromosome 5 of Human Pathogen Candida albicans Carries Multiple Genes for Negative Control of Caspofungin and Anidulafungin Susceptibility. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida albicans; Caspofungin; Chitinases; Chromosome Mapping; Chromosomes, Fungal; Drug Resistance, Fungal; Drug Tolerance; Echinocandins; Fungal Proteins; Gene Deletion; Glycosyltransferases; Humans; Lipopeptides; Microbial Sensitivity Tests; Transcription Factors	2016
Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candida tropicalis; Candidemia; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2017
Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp. Journal of medical microbiology, 2016, Volume: 65, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Respiratory System; Urine	2016
Changing epidemiology of candidaemia in Australia. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2017
Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Anidulafungin; Antifungal Agents; Austria; Candida; Candidiasis; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin	2017
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species. BMC infectious diseases, 2017, 07-10, Volume: 17, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Echinocandins; Economics, Pharmaceutical; Fluconazole; Humans; Lipopeptides; Micafungin; Taiwan; Treatment Outcome	2017
Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia. Journal of global antimicrobial resistance, 2018, Volume: 13 Topics: Anidulafungin; Antifungal Agents; Blood Culture; Candida; Candidemia; Caspofungin; Colombia; Disk Diffusion Antimicrobial Tests; Echinocandins; Genes, rRNA; High-Throughput Nucleotide Sequencing; Hospitals; Humans; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2018
Spontaneous Mutational Frequency and Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Genetic Loci; Glucosyltransferases; Humans; Micafungin; Microbial Sensitivity Tests; Mutation Rate	2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole	2019
Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. The Journal of antimicrobial chemotherapy, 2019, 08-01, Volume: 74, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Microbial Sensitivity Tests; Microbial Viability; Time Factors	2019
Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9 Topics: Anidulafungin; Antifungal Agents; Blood Culture; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2019
First report on echinocandin resistant Polish Candida isolates. Acta biochimica Polonica, 2019, Sep-12, Volume: 66, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Micafungin; Microbial Sensitivity Tests; Poland	2019
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 101 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Critical Illness; Echinocandins; Female; Humans; Male; Micafungin; Microbial Sensitivity Tests; Peritonitis; Prospective Studies	2020
Echinocandins Accelerate Particle Transport Velocity in the Murine Tracheal Epithelium: Dependency on Intracellular Ca Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Echinocandins; Epithelium; Mice	2021
Antifungal susceptibility profile of invasive Journal of medical microbiology, 2021, Volume: 70, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Pakistan; Retrospective Studies; Tertiary Care Centers	2021
Echinocandins Localized to the Target-Harboring Cell Surface Are Not Degraded but Those Entering the Vacuole Are. ACS chemical biology, 2022, 05-20, Volume: 17, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Microbial Sensitivity Tests; Vacuoles	2022
Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2022
Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan. Mycoses, 2023, Volume: 66, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Humans; Micafungin; Microbial Sensitivity Tests; Mutation; Pakistan	2023
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms. Mycopathologia, 2023, Volume: 188, Issue:1-2 Topics: Amphotericin B; Anidulafungin; Biofilms; Caspofungin; Echinocandins; Fluconazole; Micafungin	2023
Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics. Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Fluconazole; Micafungin; Microbial Sensitivity Tests; Reproducibility of Results; Voriconazole; Yeasts	2023
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris. Medical mycology, 2023, Jul-06, Volume: 61, Issue:7 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida auris; Candida glabrata; Candida parapsilosis; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Tacrolimus	2023